PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 172 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $938,000 | -21.5% | 52,084 | -68.9% | 0.00% | – |
Q1 2020 | $1,195,000 | +36.3% | 167,611 | +356.9% | 0.00% | – |
Q4 2019 | $877,000 | -83.5% | 36,687 | -81.5% | 0.00% | -100.0% |
Q3 2019 | $5,330,000 | +1.9% | 198,773 | +3.1% | 0.00% | 0.0% |
Q2 2019 | $5,229,000 | +2.7% | 192,715 | +31.3% | 0.00% | 0.0% |
Q1 2019 | $5,094,000 | -22.2% | 146,805 | -56.2% | 0.00% | -33.3% |
Q4 2018 | $6,544,000 | +58.5% | 335,284 | +116.3% | 0.00% | +50.0% |
Q3 2018 | $4,128,000 | +48.4% | 155,005 | +110.4% | 0.00% | +100.0% |
Q2 2018 | $2,782,000 | -42.2% | 73,663 | -50.0% | 0.00% | -50.0% |
Q1 2018 | $4,814,000 | +107.6% | 147,401 | +209.4% | 0.00% | +100.0% |
Q4 2017 | $2,319,000 | -25.4% | 47,637 | -17.2% | 0.00% | 0.0% |
Q3 2017 | $3,108,000 | +415.4% | 57,515 | +435.2% | 0.00% | – |
Q2 2017 | $603,000 | +222.5% | 10,747 | +125.9% | 0.00% | – |
Q1 2017 | $187,000 | -96.7% | 4,757 | -98.1% | 0.00% | -100.0% |
Q4 2016 | $5,711,000 | -4.4% | 254,491 | -3.3% | 0.00% | -25.0% |
Q3 2016 | $5,975,000 | +660.2% | 263,102 | +690.5% | 0.00% | – |
Q2 2016 | $786,000 | -3.8% | 33,284 | -16.8% | 0.00% | – |
Q1 2016 | $817,000 | -36.5% | 40,013 | +60.2% | 0.00% | -100.0% |
Q4 2015 | $1,286,000 | +8.4% | 24,983 | -10.2% | 0.00% | 0.0% |
Q3 2015 | $1,186,000 | +1074.3% | 27,830 | +1145.7% | 0.00% | – |
Q2 2015 | $101,000 | -27.3% | 2,234 | -39.2% | 0.00% | – |
Q1 2015 | $139,000 | +54.4% | 3,675 | +15.7% | 0.00% | – |
Q4 2014 | $90,000 | – | 3,175 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IFP Advisors, Inc | 0 | $0 | 0.00% |